| Ms Colleen B Bilecki, APRN, CNS | |
|
12251 S 80th Ave Ste 1520, Palos Heights, IL 60463-1290 | |
| (708) 923-4200 | |
| (708) 923-4201 |
| Full Name | Ms Colleen B Bilecki |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 21 Years |
| Location | 12251 S 80th Ave Ste 1520, Palos Heights, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942332051 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Palos Community Hospital | Palos heights, IL | Hospital |
| Central Dupage Hospital | Winfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwestern Medical Faculty Foundation | 4587576814 | 3255 |
News Archive
The Cornea and Laser Eye Institute is participating in a research study to determine if an investigational corneal inlay can safely and effectively reduce the need for reading glasses. Dr. Peter Hersh, the study doctor, will perform the procedures.
ABC News' 20/20 on Friday examined maternal health and mortality worldwide in a program titled "Giving Life: A Risky Proposition." The show was a sort of "sequel" to a series launched last year called "Be the Change: Save a Life," host Diane Sawyer said.
Amedica Corporation, a developer of a broad range of innovative, unique spine and total joint implants, announced that it has completed a $30 million financing. The financing consists of $15 million in private equity and a debt facility of $15 million. Zions First National Bank provided the debt facility, and Creation Capital of New York and Austin, Texas, acted as the placement agent for the private equity piece. Creation Capital is an established banking concern that specializes in high-growth emerging health care technologies.
Oncodesign Biotechnology(R) announced today that it has signed a licensing agreement with Janssen Pharmaceutica NV (hereinafter Janssen) related to Janssen's macrocyclic chemistry technology. Oncodesign will have exclusive access to this technology for six years.
AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITI® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITI® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.
› Verified 1 days ago
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
The Cornea and Laser Eye Institute is participating in a research study to determine if an investigational corneal inlay can safely and effectively reduce the need for reading glasses. Dr. Peter Hersh, the study doctor, will perform the procedures.
ABC News' 20/20 on Friday examined maternal health and mortality worldwide in a program titled "Giving Life: A Risky Proposition." The show was a sort of "sequel" to a series launched last year called "Be the Change: Save a Life," host Diane Sawyer said.
Amedica Corporation, a developer of a broad range of innovative, unique spine and total joint implants, announced that it has completed a $30 million financing. The financing consists of $15 million in private equity and a debt facility of $15 million. Zions First National Bank provided the debt facility, and Creation Capital of New York and Austin, Texas, acted as the placement agent for the private equity piece. Creation Capital is an established banking concern that specializes in high-growth emerging health care technologies.
Oncodesign Biotechnology(R) announced today that it has signed a licensing agreement with Janssen Pharmaceutica NV (hereinafter Janssen) related to Janssen's macrocyclic chemistry technology. Oncodesign will have exclusive access to this technology for six years.
AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITI® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITI® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.
› Verified 1 days ago
| Entity Name | Central Dupage Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033149844 PECOS PAC ID: 5890696231 Enrollment ID: O20040303000601 |
News Archive
The Cornea and Laser Eye Institute is participating in a research study to determine if an investigational corneal inlay can safely and effectively reduce the need for reading glasses. Dr. Peter Hersh, the study doctor, will perform the procedures.
ABC News' 20/20 on Friday examined maternal health and mortality worldwide in a program titled "Giving Life: A Risky Proposition." The show was a sort of "sequel" to a series launched last year called "Be the Change: Save a Life," host Diane Sawyer said.
Amedica Corporation, a developer of a broad range of innovative, unique spine and total joint implants, announced that it has completed a $30 million financing. The financing consists of $15 million in private equity and a debt facility of $15 million. Zions First National Bank provided the debt facility, and Creation Capital of New York and Austin, Texas, acted as the placement agent for the private equity piece. Creation Capital is an established banking concern that specializes in high-growth emerging health care technologies.
Oncodesign Biotechnology(R) announced today that it has signed a licensing agreement with Janssen Pharmaceutica NV (hereinafter Janssen) related to Janssen's macrocyclic chemistry technology. Oncodesign will have exclusive access to this technology for six years.
AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITI® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITI® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Colleen B Bilecki, APRN, CNS 12251 S 80th Ave Ste 1520, Palos Heights, IL 60463-1290 Ph: (708) 923-4200 | Ms Colleen B Bilecki, APRN, CNS 12251 S 80th Ave Ste 1520, Palos Heights, IL 60463-1290 Ph: (708) 923-4200 |
News Archive
The Cornea and Laser Eye Institute is participating in a research study to determine if an investigational corneal inlay can safely and effectively reduce the need for reading glasses. Dr. Peter Hersh, the study doctor, will perform the procedures.
ABC News' 20/20 on Friday examined maternal health and mortality worldwide in a program titled "Giving Life: A Risky Proposition." The show was a sort of "sequel" to a series launched last year called "Be the Change: Save a Life," host Diane Sawyer said.
Amedica Corporation, a developer of a broad range of innovative, unique spine and total joint implants, announced that it has completed a $30 million financing. The financing consists of $15 million in private equity and a debt facility of $15 million. Zions First National Bank provided the debt facility, and Creation Capital of New York and Austin, Texas, acted as the placement agent for the private equity piece. Creation Capital is an established banking concern that specializes in high-growth emerging health care technologies.
Oncodesign Biotechnology(R) announced today that it has signed a licensing agreement with Janssen Pharmaceutica NV (hereinafter Janssen) related to Janssen's macrocyclic chemistry technology. Oncodesign will have exclusive access to this technology for six years.
AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever (FMF). The INFINITI® Familial Mediterranean Fever Panel provides simultaneous multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin on the automated INFINITI® Analyzer. FMF is prominently present in the Armenian people, Sephardi Jews, Greeks, Arabs and Turks.
› Verified 1 days ago
Thomas F. Gutchewsky, APN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave Ste 1520, Palos Heights, IL 60463 Phone: 708-923-4200 Fax: 708-923-4201 | |
Valerie Saffar, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Heights, IL 60463 Phone: 708-923-5869 Fax: 708-923-5859 | |
Julie Elizabeth Vanourek, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Heights, IL 60463 Phone: 708-923-5300 Fax: 708-923-4201 | |
Alla Yakovleva, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12632 S Harlem Ave, Palos Heights, IL 60463 Phone: 708-587-0000 Fax: 708-623-7628 | |
Sumera Seraj, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 12508 S Harlem Ave, Palos Heights, IL 60463 Phone: 708-671-1685 | |
Jessica Kubicki, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12251 S 80th Ave, Palos Heights, IL 60463 Phone: 708-923-5869 Fax: 708-923-5859 | |
Susan Katello, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 12251 S. 80th Ave, Palos Heights, IL 60463 Phone: 708-923-8025 Fax: 708-923-8038 |